FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226108736> ?p ?o ?g. }

• W4226108736 endingPage "613" @default.
• W4226108736 startingPage "602" @default.
• W4226108736 abstract "Glioblastoma (GBM), the most aggressive and common form of glioma, accounts for over 13,000 death per year in the United States which indicates the importance of developing novel strategies for the treatment of this fatal malignancy. Although Arsenic trioxide (ATO) hinders the growth and survival of GBM cells, the requirement of concentrations higher than 4 µM for triggering apoptotic cell death has questioned its safety profile. Since the NF-κB signaling pathway plays a crucial role in tumorigenesis and chemo-resistance, targeting this oncogenic pathway may sensitize GBM cells to lower concentrations of ATO.Anti-tumor effects of ATO as monotherapy and in combination with Bay 11-7082 were determined using MTT, crystal violet staining, Annexin V/PI staining and scratch assays. Quantitative reverse transcription-PCR (qRT-PCR) analysis was applied to elucidate the molecular mechanisms underlying the anti-tumor activity of this combination therapy.Our results revealed that ATO and Bay 11-7082 synergistically inhibited the proliferation and survival of GBM cells. Also, it was revealed that NF-κB inhibition using Bay 11-7082 enhanced the inhibitory effects of ATO on migration of GBM cells via suppressing the expression of NF-κB target genes such as TWIST, MMP2, ICAM-1, and cathepsin B. Furthermore, combination treatment of GBM cells with ATO and Bay 11-7082 significantly induce apoptotic cell death coupled with downregulation of NF-κB anti-apoptotic target genes including Bcl-2 and IAP family members.Altogether, these findings suggest that combination therapy with ATO and Bay 11-7082 may be a promising strategy for the treatment of GBM." @default.
• W4226108736 created "2022-05-05" @default.
• W4226108736 creator A5012046587 @default.
• W4226108736 creator A5017078979 @default.
• W4226108736 creator A5034953340 @default.
• W4226108736 creator A5036536670 @default.
• W4226108736 creator A5045199940 @default.
• W4226108736 creator A5090828119 @default.
• W4226108736 date "2022-01-01" @default.
• W4226108736 modified "2023-09-24" @default.
• W4226108736 title "Blockade of Nuclear Factor-Κb (NF-Κb) Pathway Using Bay 11-7082 Enhances Arsenic Trioxide-Induced Antiproliferative Activity in U87 Glioblastoma Cells" @default.
• W4226108736 cites W1492310138 @default.
• W4226108736 cites W1581923494 @default.
• W4226108736 cites W1976293227 @default.
• W4226108736 cites W2000307839 @default.
• W4226108736 cites W2015038184 @default.
• W4226108736 cites W2016621485 @default.
• W4226108736 cites W2050493765 @default.
• W4226108736 cites W2088473501 @default.
• W4226108736 cites W2090273457 @default.
• W4226108736 cites W2091846255 @default.
• W4226108736 cites W2096439168 @default.
• W4226108736 cites W2099257830 @default.
• W4226108736 cites W2119280418 @default.
• W4226108736 cites W2237108161 @default.
• W4226108736 cites W2263159835 @default.
• W4226108736 cites W2330657714 @default.
• W4226108736 cites W2585659713 @default.
• W4226108736 cites W2607298867 @default.
• W4226108736 cites W2622964295 @default.
• W4226108736 cites W2728003117 @default.
• W4226108736 cites W2757935580 @default.
• W4226108736 cites W2765528838 @default.
• W4226108736 cites W2767515027 @default.
• W4226108736 cites W2780946965 @default.
• W4226108736 cites W2793353239 @default.
• W4226108736 cites W2918095490 @default.
• W4226108736 cites W2939195892 @default.
• W4226108736 cites W2944552859 @default.
• W4226108736 cites W2975525011 @default.
• W4226108736 cites W3011370684 @default.
• W4226108736 cites W3031224726 @default.
• W4226108736 cites W3038578130 @default.
• W4226108736 cites W3047892750 @default.
• W4226108736 cites W3088198506 @default.
• W4226108736 cites W3106688515 @default.
• W4226108736 cites W3118426931 @default.
• W4226108736 cites W4205326410 @default.
• W4226108736 cites W4288416322 @default.
• W4226108736 cites W98356699 @default.
• W4226108736 doi "https://doi.org/10.52547/rbmb.10.4.602" @default.
• W4226108736 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35291620" @default.
• W4226108736 hasPublicationYear "2022" @default.
• W4226108736 type Work @default.
• W4226108736 citedByCount "0" @default.
• W4226108736 crossrefType "journal-article" @default.
• W4226108736 hasAuthorship W4226108736A5012046587 @default.
• W4226108736 hasAuthorship W4226108736A5017078979 @default.
• W4226108736 hasAuthorship W4226108736A5034953340 @default.
• W4226108736 hasAuthorship W4226108736A5036536670 @default.
• W4226108736 hasAuthorship W4226108736A5045199940 @default.
• W4226108736 hasAuthorship W4226108736A5090828119 @default.
• W4226108736 hasBestOaLocation W42261087361 @default.
• W4226108736 hasConcept C104317684 @default.
• W4226108736 hasConcept C127561419 @default.
• W4226108736 hasConcept C185592680 @default.
• W4226108736 hasConcept C190283241 @default.
• W4226108736 hasConcept C2777730290 @default.
• W4226108736 hasConcept C2780386689 @default.
• W4226108736 hasConcept C502942594 @default.
• W4226108736 hasConcept C55493867 @default.
• W4226108736 hasConcept C71924100 @default.
• W4226108736 hasConcept C88634738 @default.
• W4226108736 hasConceptScore W4226108736C104317684 @default.
• W4226108736 hasConceptScore W4226108736C127561419 @default.
• W4226108736 hasConceptScore W4226108736C185592680 @default.
• W4226108736 hasConceptScore W4226108736C190283241 @default.
• W4226108736 hasConceptScore W4226108736C2777730290 @default.
• W4226108736 hasConceptScore W4226108736C2780386689 @default.
• W4226108736 hasConceptScore W4226108736C502942594 @default.
• W4226108736 hasConceptScore W4226108736C55493867 @default.
• W4226108736 hasConceptScore W4226108736C71924100 @default.
• W4226108736 hasConceptScore W4226108736C88634738 @default.
• W4226108736 hasIssue "4" @default.
• W4226108736 hasLocation W42261087361 @default.
• W4226108736 hasLocation W42261087362 @default.
• W4226108736 hasLocation W42261087363 @default.
• W4226108736 hasOpenAccess W4226108736 @default.
• W4226108736 hasPrimaryLocation W42261087361 @default.
• W4226108736 hasRelatedWork W2361852246 @default.
• W4226108736 hasRelatedWork W2366155705 @default.
• W4226108736 hasRelatedWork W2370380081 @default.
• W4226108736 hasRelatedWork W2392686698 @default.
• W4226108736 hasRelatedWork W2392820443 @default.
• W4226108736 hasRelatedWork W2393733452 @default.
• W4226108736 hasRelatedWork W2406878689 @default.
• W4226108736 hasRelatedWork W3140740035 @default.
• W4226108736 hasRelatedWork W3150822836 @default.

• next